Cargando…

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

The main objective was to compare the meaning of soluble angiotensin-converting enzyme-2 (sACE2) plasma levels modulation on the prognosis of two cohorts of heart failure (HF) and acute coronary syndrome (ACS). We conducted an observational clinical study where sACE2 was measured in two cohorts of H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almengló, Cristina, Couselo-Seijas, Marinela, Agra, Rosa M., Varela-Román, Alfonso, García-Acuña, José M., González-Peteiro, Mercedes, González-Juanatey, José R., Eiras, Sonia, Álvarez, Ezequiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443916/ https://www.ncbi.nlm.nih.gov/pubmed/34529122 http://dx.doi.org/10.1007/s00109-021-02129-4

Ejemplares similares

A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)
por: Agra-Bermejo, Rosa M., et al.
Publicado: (2022)

CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure
por: Agra-Bermejo, Rosa M., et al.
Publicado: (2020)

The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
por: López-Canoa, José Nicolás, et al.
Publicado: (2022)

Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open‐heart surgery
por: Couselo‐Seijas, Marinela, et al.
Publicado: (2020)

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
por: López-Otero, Diego, et al.
Publicado: (2021)

COVID-19 y tratamiento guiado con tests de diagnóstico bioquímicos y moleculares para reducir el daño cardiaco y la cardiotoxicidad
por: Eiras, Sonia, et al.
Publicado: (2020)

COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
por: Eiras, Sonia, et al.
Publicado: (2020)

Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with nicotine
por: Bru, Samuel, et al.
Publicado: (2023)

Soluble angiotensin-converting enzyme 2 association with lipid metabolism
por: Nagatomo, Izumi, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
por: Paradela-Dobarro, Beatriz, et al.
Publicado: (2017)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
por: Salgado-Barreira, Angel, et al.
Publicado: (2023)

Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets
por: Gandoy-Fieiras, Nerea, et al.
Publicado: (2020)

Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators
por: García-Vega, David, et al.
Publicado: (2022)

The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure
por: Fu, Xiaoran, et al.
Publicado: (2022)

Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue‐molecules and SGLT2i dapagliflozin
por: Almengló, Cristina, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients
por: Agra, Rosa M, et al.
Publicado: (2018)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease
por: Wysocki, Jan, et al.
Publicado: (2008)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2
por: Díaz-Troyano, Noelia, et al.
Publicado: (2022)

Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease
por: Raedle-Hurst, Tanja, et al.
Publicado: (2020)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
por: Roy-Vallejo, Emilia, et al.
Publicado: (2021)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune response
por: Bernstein, Kenneth E., et al.
Publicado: (2016)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-I-converting enzyme and its relatives
por: Riordan, James F
Publicado: (2003)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Angiotensin Converting Enzyme Activity in Alopecia Areata
por: Namazi, Mohammad Reza, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gef6sd58moaob34e5v976dg3b2